SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Phase 3 TROPiCS-02 Study: Exposure-Adjusted Incidence Rates of Adverse Events of Sacituzumab Govitecan vs. Treatment of Physician’s Choice in HR+/HER2- mBC
By
SABCS 2022 Conference Coverage
FEATURING
Sara Tolaney
By
SABCS 2022 Conference Coverage
FEATURING
Sara Tolaney
74 views
December 19, 2022
Comments 0
Login to view comments.
Click here to Login
Videos